Research article · 15 Apr 2026
Conference abstractPublished 20 Aug 2012
Glycemic control with intensive insulin treatment is fundamental to renal preservation in diabetes
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Volume 2 Issue 5 - 27 International Conference and Exhibition on Nephrology & Therapeutics August 20-22, 2012 Hilton Chicago/Northbrook, USA J Nephrol Therapeut ISSN: 2161-0959 JNT, an open access journal Nephro-2012 August 20-22, 2012 Objective: Diabetic nephropathy is the most common cause of chronic kidney disease (CKD), which progresses to end stage renal disease (ESRD) requiring dialysis. We ask if CKD progression is preventable by glycemic control with intensive insulin treatment. Methods: Data was obtained from 46 office treated patients (28F, 18 M) with established diabetes. Mean age was 62.2 (range 39 Ã?Â?Ã?¯Ã?Â?Ã?¿Ã?Â?Ã?½ 86 years. They were followed for a mean period of 14.2 (1.5 Ã?Â?Ã?¯Ã?Â?Ã?¿Ã?Â?Ã?½ 115) months. Diabetes was diagnosed by 2-h postprandial glucose (2hPPG) of > 11.1 mmol/L and treated with Glargine or detemir insulin after breakfast and dinner and regular insulin based on finger-stick glucose reading 2-h post meal and bedtime. Hypertension was treated with therapy with complete exclusion of renin- angiotensin inhibitor drugs. Glucose, urea nitrogen, serum creatinine (Scr), estimated glomerular filtration rate (eGFR), and glycosylated hemoglobin (HbA1c), and blood pressure (BP) were recorded. Values were compared between first and last visits using a paired two-tailed t-test. P 11.1 mmol/L. Results: In the all patients group, fasting glucose was significantly lower at the last versus the first visit (8.4 Ã?Â?Ã?¯Ã?Â?Ã?¿Ã?Â?Ã?½ 0.6 vs. 10.3 Ã?Â?Ã?¯Ã?Â?Ã?¿Ã?Â?Ã?½ 0.7 mmol/L, p=0.0173), and was associated with a significantly reduced Scr (100.3 + 5.2 vs. 110.9 + 7.8 Ã?Â?Ã?Â?Ã?Â?Ã?¼mol/L, p=0.0134). Little change in eGFR was found between visits. Mean eGFR was no worse than CKD stage 1 in all groups at the last visit. Less than 50% of 46 patients achieved glucose control of <11.1 mmol/L, with a highly significant reduction of HbA1c (9.14 Ã?Â?Ã?¯Ã?Â?Ã?¿Ã?Â?Ã?½ 0.52 vs. 7.60 Ã?Â?Ã?¯Ã?Â?Ã?¿Ã?Â?Ã?½ 0.45%, p=0.0148). Average BPs were normal in both visits in all groups, but diastolic BP was significantly lower in the all patients group at the last visit (77.7 Ã?Â?Ã?¯Ã?Â?Ã?¿Ã?Â?Ã?½ 1.5 vs. 81.6 Ã?Â?Ã?¯Ã?Â?Ã?¿Ã?Â?Ã?½ 1.9 mmHg, p=0.0297). Conclusion: Thus the paradigm of therapy in this study may not be affirmative in uniformly achieving tight glycemic control (< 11.1 mmol/L) but is proven to be effective in renal preservation over time in diabetes
Subjects
Nephrology & UrologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Nephrology & Therapeutics.
Brief report · 30 Mar 2026
Renal Fibrosis: Targeting Pathways For New Therapies
Brief report · 30 Mar 2026
SGLT2 Inhibitors: A New Era for Diabetic Kidney Disease
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Nephrology & Therapeutics
- SubjectNephrology & Urology
- BylineArticles whose byline prints “Anil K. Mandal”
- BylineArticles whose byline prints “Linda M Hiebert”
